MedTrace Logo

Multimodal Imaging in Central Serous Chorioretinopathy

NCT02889185 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2019-09-16

No results posted yet for this study

Summary

This study aims to assess the contribution of the multimodal imaging, combining a routine examination using Optical Coherence Tomography (OCT) with an imaging procedure using adaptive optics retinal camera.

This is a feasibility study with a limited number of patients.

Conditions

  • Central Serous Chorioretinopathy

Interventions

DEVICE

RTX1 IMAGIN EYE retinal camera

In addition to the routine examination including OCT, an imaging using RTX1 IMAGIN EYE retinal camera will be performed.

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Besancon

    lead OTHER

Principal Investigators

  • Maher Saleh, MD PhD · CHU Besançon

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2018-12-04
Completion
2018-12-04

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02889185 on ClinicalTrials.gov